Viewing StudyNCT00230477



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00230477
Status: COMPLETED
Last Update Posted: 2007-11-15
First Post: 2005-09-12

Brief Title: Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
Sponsor: University of Washington
Organization: University of Washington

Organization Data

Organization: University of Washington
Class: OTHER
Study ID: 03-5944-A03
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Washington
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
GlaxoSmithKline INDUSTRY
Gilead Sciences INDUSTRY